Stryker Corporation (SYK) Stake Maintained by B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund
B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund held its stake in Stryker Corporation (NYSE:SYK) during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 16,186 shares of the medical technology company’s stock at the close of the 2nd quarter. B.S. Pension Fund Trustee Ltd acting for the British Steel Pension Fund’s holdings in Stryker Corporation were worth $2,246,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. Parallel Advisors LLC grew its stake in shares of Stryker Corporation by 6.3% during the second quarter. Parallel Advisors LLC now owns 3,864 shares of the medical technology company’s stock worth $568,000 after acquiring an additional 228 shares during the last quarter. Essex Financial Services Inc. grew its stake in shares of Stryker Corporation by 0.6% during the second quarter. Essex Financial Services Inc. now owns 11,220 shares of the medical technology company’s stock worth $1,557,000 after acquiring an additional 62 shares during the last quarter. GVO Asset Management Ltd grew its stake in shares of Stryker Corporation by 121.2% during the second quarter. GVO Asset Management Ltd now owns 254,715 shares of the medical technology company’s stock worth $35,349,000 after acquiring an additional 139,545 shares during the last quarter. Mastrapasqua Asset Management Inc. purchased a new stake in shares of Stryker Corporation during the second quarter worth about $208,000. Finally, Winch Advisory Services LLC grew its stake in shares of Stryker Corporation by 4.4% during the second quarter. Winch Advisory Services LLC now owns 7,732 shares of the medical technology company’s stock worth $1,073,000 after acquiring an additional 329 shares during the last quarter. Institutional investors and hedge funds own 74.13% of the company’s stock.
Stryker Corporation (SYK) opened at 140.67 on Friday. The stock’s 50 day moving average price is $143.56 and its 200 day moving average price is $138.98. The firm has a market capitalization of $52.62 billion, a P/E ratio of 31.40 and a beta of 0.81. Stryker Corporation has a 52 week low of $106.48 and a 52 week high of $148.84.
Stryker Corporation (NYSE:SYK) last posted its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 EPS for the quarter, beating the consensus estimate of $1.51 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same period last year, the firm earned $1.39 EPS. On average, equities analysts expect that Stryker Corporation will post $6.46 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be issued a $0.425 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.70 annualized dividend and a dividend yield of 1.21%. Stryker Corporation’s dividend payout ratio is currently 37.95%.
COPYRIGHT VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.watchlistnews.com/stryker-corporation-syk-stake-maintained-by-b-s-pension-fund-trustee-ltd-acting-for-the-british-steel-pension-fund/1579421.html.
A number of equities research analysts recently commented on SYK shares. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $148.00 target price on shares of Stryker Corporation in a report on Thursday, August 24th. Needham & Company LLC raised Stryker Corporation from an “underperform” rating to a “hold” rating in a report on Friday, August 25th. Cantor Fitzgerald started coverage on Stryker Corporation in a report on Thursday, June 29th. They set a “neutral” rating and a $153.00 target price for the company. Morgan Stanley reaffirmed an “overweight” rating and set a $160.00 target price (up previously from $155.00) on shares of Stryker Corporation in a report on Monday, July 10th. Finally, Zacks Investment Research raised Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 target price for the company in a report on Monday, July 17th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $145.73.
In other news, insider David Floyd sold 19,305 shares of the firm’s stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the sale, the insider now directly owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The disclosure for this sale can be found here. Insiders sold a total of 25,429 shares of company stock valued at $3,686,927 over the last three months. Insiders own 7.40% of the company’s stock.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.